Observational Prospective Study of the Predicted Value of Immature Thrombocytes Counts in Three Different Groups of Critically Ill Patients

Critically Ill Patients Clinical Trial

Status Not yet recruiting

Clinical Trial Summary

Immature Platelet Fraction (IPF) is a new value in CBC blood tests Recent Studies showed that this value may be another prognostic factor in critically ill patients such as those admitted to ICU, or those with neutropenic Fever.

The purpose of the study is to check if the IPF may be used as a prognostic Factor in these patients

Clinical Trial Description

In this study we have 3 groups of patients

• Patients admitted to ICU

• Patients admitted with neutropenic fever

• Patients admitted with hip fractures it is a prospective study, not interventional, we'll take blood samples of these patients including CBC count eith IPF and other inflammation markers such as CRP and we'll compare CRP to IPF in addition to clinical follow-up of the patient till discharge.

At the end of this study we'll compare the efficacy of IPF as a prognostic Factor in these patients ;

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Critical Illness
• Critically Ill Patients
• Febrile Neutropenia
• Hip Fractures
• Neutropenic Fever Patients
• Patients With Hip Fractures

• NCT number: NCT02016859
• Study type: Observational [Patient Registry]
• Source: Rambam Health Care Campus
• Contact: Yishai Ofran, Doctor
• Phone: 009720502061524
• Email: Y_ofran@ramabm.health.gov.il
• Status: Not yet recruiting
• Phase: N/A
• Start date: January 2014
• Completion date: November 2014